Based on the analysis of scRNA-seq, the expression of FDX1, DLD and SLC31A1 was much higher in non-tumor tissues than those in tumor tissues, consistent with our findings from a bulk sequencing analysis (Figure 2H). The gene discussed is SLC31A1; the disease is neoplasm.